Zadnji put ažurirano :
19/11/2024
lijek protiv karcinoma   Azacitidine  
injekcija
Stabilizacija rješenja Stabilnost mješavine Stabilizacijski faktor Kompatibilnosti način davanja lijeka Bibliografija pdf
   Kemijska struktura  

Nekomercijalni   Nekomercijalni     

Zaštićeni nazivi su indikativni i sastav ekscipijensa može biti različit ovisno o državi i laboratorijima

Amilix Argentina
Arquimes Argentina
Azacimyl Čile
Azacitidina Argentina, Čile, Peru
Azacitidine S A D
Azacor Peru
Azadin Turska
Azamex Argentina
Azanova Argentina
Azateva Argentina
Azida Turska
Azitech Argentina
Iclacitidina Peru
Iterbil Argentina
Maturus Argentina
Mietozitidina Argentina, Peru
Nimodac Argentina
Remitiva Argentina, Čile
Tazadir Argentina
Vidaza Argentina, Belgija, Čile, Francuska, Island, Kanada, Kolumbija, Malezija, Meksiko, Njemačka, Norveška, novi Zeland, Peru, Rumunjska, S A D, Španjolska, Švicarska, Turska, Velika Britanija
Wunduza Čile
Zacidonel Meksiko
Zylatadina Argentina
Bibliografija   injekcija   Bibliografija : Azacitidine  
Vrsta Publikacija
414 Časopis Den Hartigh J, Brandenburg HCR, Vermeij P.
Stability of azacitidine in lactated Ringer’s injection frozen in polypropylene syringes.
Am J Hosp Pharm 1989 ; 46: 2500-2505.
1039 Časopis Cheung YW, Vishnuvajjala BR, Morris NL, Flora KP.
Stability of azacitidine in infusion fluids.
Am J Hosp Pharm 1984 ; 41: 1156-1159.
3204 Časopis Duriez A, Vigneron J.H, Zenier H.A, May I, Demoré B.M.
Stability of Azacitidine Suspensions.
Ann Pharmacotherapy 2011 ;45, 4:546.
3236 Laboratorija Azacitidine (Vidaza®) - Résumé des caractéristiques du produit
Celgene 2011
3246 Plakat Vieillard V, Appudurai O, Voytenko S, Astier A, Paul M.
Stabilité physico-chimique de la suspension d'azacitidine (25 mg/mL) conservée à 4°C.
SFPO Congress Mandelieu, France 2011
3351 Časopis Walker S.E, Charbonneau L.F, Law S, Earle C.
Stability of Azacitidine in Sterile Water for Injection.
Can J Hosp Pharm 2012 ; 65, 5: 352-359
3534 Časopis Legeron R, Xuereb F, Djabarouti S, Saux M.C, Breilh D.
Chemical stability of azacitidine suspensions for injection after cold-chain reconstitution of powder and storage
Am J Health-Syst Pharm 2013 ; 70:2137-2142
3816 Plakat Balouzet C, Chanat C, Jobard M, Brandely-Piat ML, Chast F.
Stabilité des poches d'azacitidine pour injection intraveineuse (1- 4 et 2,4 mg/mL) conservées à 4°C.
SFPO Congress, Nantes, France 2015
3818 Časopis Balouzet C, Chanat C, Jobard M, Brandely-Piat M-L, Chast F.
Stability of 25 mg/mL 5-azacitidine suspension kept in fridge after freezing.
Pharmaceutical Technology in Hospital Pharmacy 2017 ;2, 1:11-16.
4227 Plakat Tyono I, Law S, Charbonneau L.F, Walker S.E.
Stability of Azacitidine Solutions In Sterile Water for Injection.
Prof Practice Conference - Canadian Society of PH 2019
4628 Časopis Iudicello A, Genovese F, Strusi V, Dominici M, Ruozi B.
Development and Validation of a New Storage Procedure to Extend the In-Use Stability of Azacitidine in Pharmaceutical Formulations.
Pharmaceuticals 2021 ; 14, 943.
4697 Časopis Trambloy Q, Vigneron J, Clarot I, Blaise F, D’Huart E, Demoré B.
Physicochemical stability of azacitidine suspensions at 25 mg/mL in polypropylene syringes stored under different conditions of storage.
Pharmaceutical Technology in Hospital Pharmacy 2022 2022; 7(1): 20220003

  Mentions Légales